| Identification | Back Directory | [Name]
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- | [CAS]
2751609-45-5 | [Synonyms]
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- | [Molecular Formula]
C28H33F4N5 | [MOL File]
2751609-45-5.mol | [Molecular Weight]
515.59 |
| Hazard Information | Back Directory | [Uses]
Estrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4)[1]. | [References]
[1] Zhang Yan, et al. Estrogen receptor modulator compounds and their uses. Patent WO2021249533A1. |
|
|